News

We have a winner in the battle of the weight loss drugs. In a head-to-head randomised controlled trial, tirzepatide (Mounjaro ...
Despite its expensive valuation and declining estimates, we suggest investors hold LLY stock as the company boasts solid ...
A new analysis being presented at the European Congress on Obesity (ECO25) in Malaga, Spain (11–14 May), finds that around ...
Dianne Carr had tried 'almost every fad diet under the sun', but was unable to keep the weight off - then she turned to ...
Zepbound — the brand name for tirzepatide — is the most effective GLP-1 medication for weight loss, according to one study.
Dianne Carr had tried 'almost every fad diet under the sun', but was unable to keep the weight off - then she turned to Mounjaro ...
Mounjaro. Ozempic. Wegovy. Zepbound. All these are brand names linked in some way to diabetes and weight loss-or, as the ...
Ohio Attorney General Dave Yost sent letters to 14 medical spas warning them to stop making false or misleading claims about ...
For us, halfway through the 2020s, it’s Mounjaro vs Ozempic, the battle of the fat jabs. In the first ever head-to-head ...
Gill Foster, 58, tipped the scales at 17st 10lb when she decided to start Mounjaro injections with NHS-backed healthy eating ...
Fact checked by Nick Blackmer Tirzepatide and semaglutide, the ingredients in popular weight loss drugs, can both cause side ...
Novo Nordisk is making yet another bet on obesity, offering Septerna more than $200 million in upfront and near-term payments ...